Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 5, 2004, Pages 736-743

  Bates, Mary E ^a   Liu, Lin Ying ^a   Esnault, Stephane ^a   Stout, Barbara A ^a   Fonkem, Ekokobe ^a   Kung, Vanderlene ^a   Sedgwick, Julie B ^a   Kelly, Elizabeth A B ^a   Bates, Douglas M ^a   Malter, James S ^a   Busse, William W ^a   Bertics, Paul J ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BIOCHEMICAL MARKER; CD24 ANTIGEN; CD66E ANTIGEN; CYCLIN D3; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 3 RECEPTOR ALPHA; INTERLEUKIN 5; LYMPHOTOXIN BETA; PROTEIN; PROTEIN KINASE PIM 1; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ALPHA CHAIN; ARTICLE; BLOOD CELL; CELL SURFACE; CYTOKINE PRODUCTION; DNA MICROARRAY; DNA RESPONSIVE ELEMENT; EOSINOPHIL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE ISOLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG LAVAGE; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; UNINDEXED SEQUENCE; UPREGULATION;

BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; EOSINOPHILS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-5; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RESPIRATORY SYSTEM;

EID: 2342480598     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0234OC     Document Type: Article

References (41)

1. Giembycz, M. A., and M. A. Lindsay. 1999. Pharmacology of the eosinophil. Pharmacol. Rev. 51:213-340.
2. Hamelmann, E., and E. W. Gelfand. 1999. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness. Int. Arch. Allergy Immunol. 120:8-16.
3. Rothenberg, M. E., R. Ownbey, P. D. Mehlhop, P. M. Loiselle, M. van de Rijn, J. V. Bonventre, H. C. Oettgen, P. Leder, and A. D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2:334-348.
4. Foster, P. S., A. W. Mould, M. Yang, J. Mackenzie, J. Mattes, S. P. Hogan, S. Mahalingam, A. N. McKenzie, M. E. Rothenberg, I. G. Young, K. I. Matthaei, and D. C. Webb. 2001. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179:173-181.
5. Yousefi, S., K. Blaser, and H. U. Simon. 1997. Activation of signaling pathways and prevention of apoptosis by cytokines in eosinophils. Int. Arch. Allergy Immunol. 112:9-12.
6. Bates, M. E., V. L. Green, and P. J. Bertics. 2000. ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesis. J. Biol. Chem. 275:10968-10975.
7. Koenderman, L., T. van der Bruggen, R. C. Schweizer, R. A. Warringa, P. Coffer, E. Caldenhoven, J. W. Lammers, and J. A. Raaijmakers. 1996. Eosinophil priming by cytokines: from cellular signal to in vivo modulation. Eur. Respir. J. 22:119s-125s.
8. Sedgwick, J. B., W. J. Calhoun, R. F. Vrtis, M. E. Bates, P. K. McAllister, and W. W. Busse. 1992. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 149:3710-3718.
9. Capowski, E. E., S. Esnault, S. Bhattacharya, and J. S. Malter. 2001. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J. Immunol. 167:5970-5976.
10. Esnault, S., and J. S. Malter. 1999. Primary peripheral blood eosinophils rapidly degrade transfected granulocyte-macrophage colony-stimulating factor mRNA. J. Immunol. 163:5228-5234.
11. Walz, T. M., B. K. Nishikawa, C. Malm, K. Briheim, and A. Wasteson. 1994. Transforming growth factor alpha expression in normal human blood eosinophils: differential regulation by granulocyte-macrophage colony-stimulating factor and interleukin-3. Leukemia 8:612-619.
12. Bodey, K. J., A. E. Semper, A. E. Redington, J. Madden, L. M. Teran, S. T. Holgate, and A. J. Frew. 1999. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 54:1083-1093.
13. Kelly, E. A., W. W. Busse, and N. N. Jarjour. 2000. Inhaled budesonide decreases airway inflammatory response to allergen. Am. J. Respir. Crit. Care Med. 162:883-890.
14. Hansel, T. T., I. J. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145:105-110.
15. Lelivelt, M. J., and M. R. Culbertson. 1999. Yeast Upf proteins required for RNA surveillance affect global expression of the yeast transcriptome. Mol. Cell. Biol. 19:6710-6719.
16. Li, C., and W. H. Wong. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98:31-36.
17. Box, G. E. P., W. G. Hunter, and J. S. Hunter. 1978. Statistics for Experimentors: An Introduction to Design, Data Analysis, and Model Building. Wiley, New York.
18. Bates, M. E., W. W. Busse, and P. J. Bertics. 1998. Interleukin 5 signals through Shc and Grb2 in human eosinophils. Am. J. Respir. Cell Mol. Biol. 18:75-83.
19. Lopez, A. F., D. J. Williamson, J. R. Gamble, C. G. Begley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 78:1220-1228.
20. Matsumoto, K., J. Appiah-Pippim, R. P. Schleimer, C. A. Bickel, L. A. Beck, and B. S. Bochner. 1998. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am. J. Respir. Cell Mol. Biol. 18:860-866.
21. Temple, R., E. Allen, J. Fordham, S. Phipps, H. C. Schneider, K. Lindauer, I. Hayes, J. Lockey, K. Pollock, and R. Jupp. 2001. Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes. Am. J. Respir. Cell Mol. Biol. 25:425-433.
22. Zhang, Y., S. F. Schlossman, R. A. Edwards, C. N. Ou, J. Gu, and M. X. Wu. 2002. Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc. Natl. Acad. Sci. USA 99:878-883.
23. Sedgwick, J. B., W. J. Calhoun, G. J. Gleich, H. Kita, J. S. Abrams, L. B. Schwartz, B. Volovitz, M. Ben-Yaakov, and W. W. Busse. 1991. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am. Rev. Respir. Dis. 144:1274-1281.
24. Liu, L., J. Sedgwick, M. Bates, R. Vrtis, J. Gern, H. Kita, N. Jarjour, W. Busse, and E. Kelly. 2002. Decreased expression of membrane IL-5 receptor α on human eosinophils: I. Loss of membrane IL-5 receptor α on airway eosinophils and increased soluble IL-5 receptor α in the airway after allergen challenge. J. Immunol. 169:6452-6458.
25. Julius, P., W. Luttmann, B. Knoechel, C. Kroegel, H. Matthys, and J. C. Virchow, Jr. 1999. CD69 surface expression on human lung eosinophils after segmental allergen provocation. Eur. Respir. J. 13:1253-1259.
26. Kroegel, C., M. C. Liu, W. C. Hubbard, L. M. Lichtenstein, and B. S. Bochner. 1994. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. J. Allergy Clin. Immunol. 93:725-734.
27. Nagase, H., K. Kudo, S. Izumi, K. Ohta, N. Kobayashi, M. Yamaguchi, K. Matsushima, Y. Morita, K. Yamamoto, and K. Hirai. 2001. Chemokine receptor expression profile of eosinophils at inflamed tissue sites: decreased CCR3 and increased CXCR4 expression by lung eosinophils. J. Allergy Clin. Immunol. 108:563-569.
28. Aigner, S., Z. M. Sthoeger, M. Fogel, E. Weber, J. Zarn, M. Ruppert, Y. Zeller, D. Vestweber, R. Stahel, M. Sammar, and P. Altevogt. 1997. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89:3385-3395.
29. Ware, C. F., T. L. VanArsdale, P. D. Crowe, and J. L. Browning. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198:175-218.
30. Cannella, B., I. D. Sizing, C. D. Benjamin, J. L. Browning, and C. S. Raine. 1997. Antibodies to lymphotoxin alpha (LT alpha) and LT beta recognize different glial cell types in the central nervous system. J. Neuroimmunol. 78:172-179.
31. Stout, B. A., M. E. Bates, and P. J. Bertics. 2003. Interleukin-5 and granulocyte/macrophage colony stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J. Immunol. (In press)
32. Woolley, K. L., E. Adelroth, M. J. Woolley, I. Ramis, J. S. Abrams, M. Jordana, and P. M. O'Byrne. 1996. Interleukin-3 in bronchial biopsies from nonasthmatics and patients with mild and allergen-induced asthma. Am. J. Respir. Crit. Care Med. 153:350-355.
33. Park, C. S., Y. S. Choi, S. Y. Ki, S. H. Moon, S. W. Jeong, S. T. Uh, and Y. H. Kim. 1998. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur. Respir. J. 12:872-878.
34. Jarjour, N. N., W. J. Calhoun, E. A. Kelly, G. J. Gleich, L. B. Schwartz, and W. W. Busse. 1997. The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am. J. Respir. Crit. Care Med. 155:1515-1521.
35. Mawhorter, S. D., D. A. Stephany, E. A. Ottesen, and T. B. Nutman. 1996. Identification of surface molecules associated with physiologic activation of eosinophils: application of whole-blood flow cytometry to eosinophils. J. Immunol. 156:4851-4858.
36. Hammarstrom, S. 1999. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9:67-81.
37. Skubitz, K. M., K. D. Campbell, and A. P. N. Skubitz. 1996. Cd66a, Cd66b, Cd66c, and Cd66d Each Independently Stimulate Neutrophils. J. Leukoc. Biol. 60:106-117.
38. Tsukadaira, A., Y. Okubo, K. Kitano, S. Horie, T. Momose, S. Takashi, J. Suzuki, M. Isobe, and M. Sekiguchi. 1999. Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc. 20:39-44.
39. Rodgers, S., R. C. Rees, and B. W. Hancock. 1994. Changes in the phenotypic characteristics of eosinophils from patients receiving recombinant human interleukin-2 (rhIL-2) therapy. Br. J. Haematol. 86:746-753.
40. Mire-Sluis, A., L. A. Page, M. Wadhwa, and R. Thorpe. 1995. Evidence for a signaling role for the alpha chains of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors: divergent signaling pathways between GM-CSF/IL-3 and IL-5. Blood 86:2679-2688.
41. Cornelis, S., I. Fache, J. Van der Heyden, Y. Guisez, J. Tavernier, R. Devos, W. Fiers, and G. Plaetinck. 1995. Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction. Eur. J. Immunol. 25:1857-1864.